MIRA
INFORM REPORT
|
Report Date : |
11.04.2008 |
IDENTIFICATION
DETAILS
|
Name : |
AEGIS PUBLIC LIMITED |
|
|
|
|
Formerly Known as : |
AEGIS CHEMICALS LIMITED |
|
|
|
|
Registered Office : |
Egates Industrial Area, 17,Athinon Street, 2643 Nicosia |
|
|
|
|
Country : |
Cyprus |
|
|
|
|
Date of Incorporation : |
01.01.1989 |
|
|
|
|
Com. Reg. No.: |
C3678 Nicosia |
|
|
|
|
Legal Form : |
Public Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacture of Basic Pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NAME & ADDRESS
NAME INQUIRED
UNDER: Aegis Ltd
Correct Registered
Name: AEGIS PUBLIC LIMITED
Address: Egates
Industrial Area, 17,Athinon Street
2643 Nicosia CYPRUS
P.O.Box: 28629
- 2081
Telephone: +357-22-624040
Fax: +357-22-624062
Email: aegis@aegispharma.eu
Web: www.aegispharma.com
LEGAL STATUS
Legal Form: Public Limited
Liability Company
Date of
foundation: 01.01.1989
Registration
number and city: C3678 Nicosia
Registration date:
21.07.1989
Present Style
Adopted on: 20.11.2000
Former
registration name: AEGIS
CHEMICALS LIMITED, valid since: 21.07.1989, until: 12.12.1991
National ID
NIC039604
VAT number
10036748R
Former company names
AEGIS CHEMICALS
LIMITED
PAYMENT
No complaints
GOOD FOR AMOUNT
& TERMS OF INQUIRY: Yes
COMMERCIAL
MORALITY: Good
FINANCIAL
STRENGTH: Good
INSOLVENCY: According to available information sources the company is not in a insolvency/Preliminary/debt regulation proceeding.
PRINCIPALS
SHAREHOLDERS
|
Full Name |
Function |
Nationality |
EQUITY |
Address |
|
KAMAR B.V. |
Shareholder |
|
7.26% |
|
|
T.C. CHRISTOFOROU LIMITED |
Shareholder |
|
2.78% |
7, Kleovoulou Papakyriakou Street |
|
CLR INVESTMENT FUND PUBLIC LIMITED |
Shareholder |
|
51.88% |
|
|
PHADISCO LTD |
Shareholder |
|
1.51% |
Corner Makarios Avenue & Arnaldas - Christodoulides Bldg |
|
OTHERS (C3678) |
Shareholder |
|
36.57% |
|
MANAGEMENT
|
Full Name |
Age |
Function |
Qualification |
Experience |
Address |
|
Mr. Ioannis Christodoulides |
40 |
Director |
N/A |
N/A |
CYPRUS |
|
Mr. Pavlos Kouris |
|
Director |
N/A |
N/A |
22,Annis Komninis |
|
Panagiotis Zavallis |
|
Secretary |
N/A |
N/A |
5th Floor,Apt 501, 5,San Sousi |
|
Mr. George Mouskides |
|
Director |
N/A |
N/A |
1,Onisillou street |
|
Mr. Aristotelis Stylianides |
76 |
Chairman |
Engineer CYTA |
Sales Mgr. |
1,Efterpis Street |
|
Dr. Nicolas Stylianides |
44 |
Director |
Ph. D. Chemistry |
Sales Mgr. |
35,Thermopylon Street |
|
Mr. Ioannis Strongylos |
|
Director |
N/A |
N/A |
Entechno Bldg,l Apt1 , 73,Prodromou Street |
|
Mr. Loucas Louca |
|
Director |
N/A |
N/A |
15,Elia papakyriakou Street |
ACTIVITIES
Importers &
Wholesalers & Distributors & Exporters
OPERATIONS
NACE
2441 Manufacture of basic pharmaceutical products
2442 Manufacture of pharmaceutical preparations
5146 Wholesale of pharmaceutical goods
SIC
2834 Pharmaceutical Preparations
Importers (100%) of raw materials
The Present company is a manufacture of a wide range of uncoated, coated,
chewable, slow and modified release tablets. Also they manufacture dry powders
for suspensions and agglomerate powders for better flow and dissolution
properties.
MOTOR
VEHICLES
2008
Number of vans owned:
2
Total number of vehicles 2
IMPORTS
EUROPE, INDIA
Payment terms:
Credit Facilities 60 days
EXPORTS
NETHERLANDS,
UNITED KINGDOM, VIET NAM, KENYA, SINGAPORE, FRANCE, AUSTRIA, GERMANY, MALTA,
JORDAN
Payment terms:
O/A (Open Account)
L/C Base (Letter of Credit)
TRADE SUPPLIERS
|
NUMBER
OF EMPLOYEES
80
DESCRIPTION
OF PREMISES
|
Address: |
Egates Industrial Area, 17,Athinon Street |
|
Type of premises: |
Premises |
|
SIZE: |
1500 Sq. Metres |
|
Type of ownership: |
owned |
|
Condition: |
Good |
HEADQUARTERS
The company is operating
from owned premises, which are located at the address given overleaf. Premises
are spacious, covering a total area of 1,500 m², comprised of offices, the
factory and warehouses
BRANCHES
None
BANKERS
HELLENIC BANK
PUBLIC COMPANY LIMITED
Corner 200 Limassol Avenue & Athalassa Avenue,2025 Nicosia, P.O Box 24747 -
1394 Nicosia, Tel: 357 22500000 Fax: 357 22500050,
USD ACCOUNT: 119-07-02936-401
EURO ACCOUNT: 119-01-02936-403
SHARE CAPITAL
|
||||||||||||||||||||||||||||||||||||||||
CHARGES
|
05.02.1993 |
Floating Charge on all Company's Assets |
CYP 300,000.00 |
|
in f/o:Hellenic Bank
Public Company Limited |
|
30.06.1993 |
Mortgage |
CYP 300,000.00 |
|
in f/o:Hellenic
Bank Public Company Limited |
|
22.05.2001 |
Mortgage |
CYP 300,000.00 |
|
in f/o:Hellenic
Bank Public Company Limited |
|
25.09.2000 |
Floating Charge on all Company's Assets |
CYP 100,000.00 |
|
in f/o:Hellenic
Bank Public Company Limited |
|
28.01.2002 |
Floating Charge on all Company's Assets |
CYP 230,000.00 |
|
in f/o:Hellenic
Bank Public Company Limited |
|
21.07.2004 |
Floating Charge on all Company's Assets |
CYP 20,000.00 |
|
in f/o:Hellenic
Bank Public Company Limited |
|
28.06.2006 |
Floating Charge on all Company's Assets |
CYP 220,000.00 |
|
in f/o:Hellenic
Bank Public Company Limited |
|
27.06.2007 |
Fixed Charge on the Company's Machinery |
CYP 750,000.00 |
|
in f/o:Hellenic
Bank Public Company Limited |
|
14.12.2007 |
Fixed Charge on the Company's Machinery |
CYP 95,000.00 |
|
in f/o:Hellenic
Bank Public Company Limited |
|
14.12.2007 |
Mortgage |
CYP 60,000.00 |
|
in f/o:Hellenic
Bank Public Company Limited |
|
14.12.2007 |
Mortgage |
CYP 60,000.00 |
|
in f/o:Hellenic
Bank Public Company Limited |
GENERAL COMMENTS
The present Public
Limited Liability Company was incorporated on 21/07/1989.
The company is involved in the production and trade of quality pharmaceuticals
through licensing agreements, as well as their owned branded products. The
company’s actual activities started in 1994.
About 85% of the company’s production is exported, and the rest is absorbed by
the local market.
AEGIS strategy is to offer drugs therapeutically equivalent and interchangeable
with the products of the industry leaders, at fair prices. They are the alternative
to expensive healthcare. They manufacture over 100 products in various
strengths and pack sizes.
Contact Person: Mr Panayiotis Zavallis
Position: Secretary
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)